An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Overview of attention for article published in New England Journal of Medicine, June 2019
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (98th percentile)
Mentioned by
- news
- 130 news outlets
- blogs
- 16 blogs
- policy
- 2 policy sources
- 554 X users
- patent
- 36 patents
- 16 Facebook pages
- wikipedia
- 9 Wikipedia pages
- 9 Redditors
- f1000
- 1 research highlight platform
- guideline
- 6 clinical guideline sources
- bluesky
- 1 Bluesky user
Readers on
- mendeley
- 1040 Mendeley